Fundraising Fox

Cardiva Medical

Santa Clara, US · Delaware corporation · 4 known investors

Cardiva Medical, part of Haemonetics, develops the VASCADE family of vascular closure systems, including venous and arterial closure devices used in cardiovascular procedures. It is part of a medical technology company serving hospitals and blood collection centers with blood management, plasma collection, hemostasis analysis, and vascular closure products.

HardwareHealthtechMedical Devices

Founders & leadership

GL
George LeeNamed on SEC filing
LG
Lisa GarrettNamed on SEC filing
MB
Michael BornitzNamed on SEC filing
RA
Rick AndersonNamed on SEC filing
JR
John RussellNamed on SEC filing
AL
Augustine LienNamed on SEC filing
MC
Matthew CrawfordNamed on SEC filing
JB
Justin BallottaNamed on SEC filing

Board

PEPaul Enever
Paul EneverinMember Board of Directors2014–2021Partner at Evidity Health Capital

Investors · 4

Essex Woodlands Healthcare PartnersNew York · $20M – $80M
Evidity Health CapitalNew York · $5M
Luther King Capital ManagementreportedFort Worth
PTV Healthcare CapitalreportedSingapore

Reported raises · per SEC filings

Form D private placements

$84.2M disclosed across 2 rounds · 2017–2020

▶$45MraisedJul 2020 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew CrawfordDirector
  • Robert WhiteDirector
  • Lisa GarrettExecutive Officer
  • Justin BallottaExecutive Officer
  • Paul EneverDirector
  • Roger OwensExecutive Officer
  • John RussellExecutive Officer, Director
  • Michael BornitzDirector
  • Augustine LienDirector
  • Jeryl HillemanDirector
  • Thomas BarfieldDirector
  • George LeeDirector
  • Zia YassinzadehExecutive Officer
Offering amount
$45M
Amount sold
$45M
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$39.2MraisedJan 2018 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul EneverDirector
  • George LeeDirector
  • Lisa GarrettExecutive Officer
  • Michael BornitzDirector
  • Rick AndersonDirector
  • John RussellExecutive Officer, Director
  • Augustine LienDirector
  • Matthew CrawfordDirector
  • Justin BallottaExecutive Officer
Offering amount
$49.9M
Amount sold
$39.2M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Cardiva Medical raises funds to commercialise vascular closure systemsmedicaldevice-network.com · Jul 2020Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partnersglobenewswire.com · Jul 2020Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures - BioSpacebiospace.com · Feb 2018Cardiva Medical Inc says raises about $28 mln in equity financing | Reutersreuters.com · Mar 2017Cardiva Medical Raises $30m in Equity Financing - FinSMEsfinsmes.com · Mar 2017Cardiva Medical Raises $30 Millionprnewswire.com · Mar 2017

Frequently asked questions

What does Cardiva Medical do?
Cardiva Medical, part of Haemonetics, develops the VASCADE family of vascular closure systems, including venous and arterial closure devices used in cardiovascular procedures. It is part of a medical technology company serving hospitals and blood collection centers with blood management, plasma collection, hemostasis analysis, and vascular closure products.
Who are Cardiva Medical's investors?
Cardiva Medical's investors include Essex Woodlands Healthcare Partners, Evidity Health Capital, Luther King Capital Management, PTV Healthcare Capital.
How much funding has Cardiva Medical raised?
Cardiva Medical has disclosed $84.2M raised across 2 rounds.
Where is Cardiva Medical headquartered?
Cardiva Medical is headquartered in Santa Clara, US.